Company Updates

The Company yesterday announced results of its recent 2 for 3 non-renounceable rights issue which closed on 12 November 2012. Some corrections are required to the results announced and to reflect the terms of the offer which included a 19.9% cap and scale-back in respect of applications for additional shares in excess of a shareholder’s […]

Key points AmpliPhi and Special Phage Services have completed their share exchange transaction – combined company now trading as AmpliPhi Complementary technologies and expertise in bacteriophage-based therapies have created world-leading bacteriophage company Pipeline of innovative development stage anti-bacterial therapies focused on antibiotic-resistant infections – applications in human and veterinary health Management team led by AmpliPhi’s […]

Linc Energy Ltd (“the Company”) is pleased to announce its first Quarter 2013 financial results for its wholly-owned subsidiary Linc Energy Resources, Inc (“LER”). LER is the head entity of the company’s Oil and Gas Group headquartered in Houston, Texas. As previously announced, on 12 October 2012 the Company through its wholly-owned subsidiaries issued $US254 […]

Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY) announces that its wholly owned subsidiary, Vegenics Pty Ltd, has entered into a non-exclusive worldwide licence agreement with one of the world’s leading providers of life science research and clinical diagnostics products, Bio-Rad Laboratories, Inc., (NYSE: BIO and BIOb), to market research assays for the detection of VEGF-C and/or VEGF-D […]

Oil Basins Limited (ASX codes: OBL, OBLOB and/or Company) is pleased to advise the Australian Stock exchange that it has secured a Strategic Cornerstone Investment in the Company by Fortescue Metals Group Ltd (ASX code: FMG). The FMG investment will be by way of an immediate Strategic Placement comprising 120 million new fully paid OBL […]

Cobar Consolidated Resources Limited (ASX:CCU) announced today that Grant Davidson, General Manager Operations, has tendered his resignation from the Company for personal reasons. Managing Director Ian Lawrence said, “Grant has tendered his resignation, which has been accepted. On behalf of the Board I thank Grant for his contribution over the past year, overseeing construction and […]

..During Dr McColl’s two years at Starpharma he was a driver of partnering transactions and had a lead role in the in-house docetaxel oncology drug program ..Big pharma experience and completed approximately 50 research, development, licensing, M&A and other partnering deals ..Considerable global experience and strong international networks Starpharma Vice President and respected biotechnology professional […]

Gold Anomaly Ltd announced that its two for three non-renounceable rights issue closed on November 12, 2012. Under the rights issue the Company sought to raise up to AUD 3,745,558.22 from eligible shareholders. Application funds totaling AUD 3,671,331.10 were received and therefore the issue was undersubscribed by AUD 74,227.12. As the rights issue was underwritten […]

AnaeCo welcomed on 18 October, 2012 senior officials from the Beijing State-owned Assets Management Company Limited (BSAM) and Dynagreen to Western Australia to assess the cutting-edge DiCOM™ System facility in Shenton Park, Perth and to conduct a strategic review of the potential opportunities for the DiCOM™ System in China. AnaeCo and Dynagreen signed a Memorandum […]